Enhancement of aerobic fitness improves social functioning in individuals with schizophrenia.

Individuals with schizophrenia display substantial deficits in social functioning (SF), characterized by chronic, lifelong presentations. Yet, at present there are few effective interventions to enhance SF in this population. Emerging evidence from studies of clinical populations that display similar SF deficits suggests that aerobic exercise (AE) may improve social skills. However, this putative impact has not been investigated in schizophrenia. Employing a single-blind, randomized clinical trial design, 33 individuals with schizophrenia were randomized to receive 12 weeks of Treatment-As-Usual (TAU; n = 17) or TAU + AE (n = 16) utilizing active-play video games (Xbox 360 Kinect) and traditional AE equipment. Participants completed an evaluation of aerobic fitness (VO2max) as well as self-, informant-, and clinician-reported SF measures at baseline and after 12 weeks. Twenty-six participants completed the study (79%; TAU = 13; AE = 13). At follow-up, the AE participants improved their VO2max by 18.0% versus - 0.5% in the controls (group x time interaction, F1,24 = 12.88; p = .002). Hierarchical stepwise regression analyses indicated improvements in VO2max significantly predicted enhancement in SF as indexed by self-, informant-, and clinician-reported measures, predicting 47%, 33%, and 25% of the variance, respectively (controlling for baseline demographics, medications, mood symptoms, and social networks). Compared to the TAU group, AE participants reported significant improvement in SF (23.0% vs. - 4.2%; group × time interaction, F1,24 = 7.48, p = .012). The results indicate that VO2max enhancement leads to improvements in SF in people with schizophrenia. Furthermore, low VO2max represents a modifiable risk factor of SF in people with schizophrenia, for which AE training offers a safe, non-stigmatizing, and nearly side-effect-free intervention.

Background

Individuals with schizophrenia display substantial deficits in social functioning (SF) [1]. These deficits, which often predate the onset of psychosis [2, 3], are characterized by chronic, lifelong presentations [4-7] that have been linked to heightened experiences of stigma [8], diminished quality of life, and disability [9]. Thus, poor SF represents a public health concern [10, 11] and an important target for interventions in this population [12].

Consistent with this view, interest in the development of interventions aiming to ameliorate poor SF in schizophrenia and related disorders has grown substantially in recent years [13]. A number of therapeutic approaches have been employed including cognitive remediation, cognitive behavioral therapy (CBT), third-wave therapies, as well as pharmacotherapy. However, evidence supporting the efficacy of these interventions has been mixed. A meta-analysis of cognitive remediation interventions for individuals with early psychosis indicated a small but significant effect size [14]. Yet, a recent meta-analysis of studies in individuals at clinical high-risk for psychosis reported no significant improvement in at 2- to 3-month follow-ups [15]. Interventions for individuals with schizophrenia employing CBT models have shown more promise. A meta-analysis indicated a large positive effect of CBT on SF [16], though many of the included studies were of low quality [16]. A more recent meta-analysis evaluating the effectiveness of CBT for psychosis showed small, but significant effect sizes for functioning by end-of-trials that became non-significant at follow-ups [17]. Likewise, recent findings suggest third-wave cognitive-behavioral interventions for individuals with schizophrenia may be helpful, albeit with small effect sizes, as has been demonstrated in a recent meta-analysis [18]. Finally, pharmacological interventions have demonstrated limited efficacy in ameliorating poor SF in schizophrenia. Results from the CATIE trial, a large randomized clinical trial that followed-up participants for up to 18 months, noted modest improvements in SF, with no differences in ratings after 6, 12, or 18 months [19]. Altogether, these findings indicate a limited to modest efficacy of available treatments for poor SF in schizophrenia. Hence, while efforts to address social dysfunction in this population have increased over the past decade, progress to date has been modest, and there remains a critical need to identify and develop new treatment approaches to target poor SF in schizophrenia.

One approach that has been shown to enhance SF among other clinical populations presenting with social deficits is aerobic exercise training (AE). A meta-analysis of 16 AE studies of individuals with autism spectrum disorder indicated significant improvements in social skills [20], with jogging and swimming being the most frequently applied therapeutic exercise activities. Specifically, social interaction skills showed significant benefits, with an overall average improvement of 39.1% [20]. Similarly, a systematic review of research on exercise interventions in individuals with autism spectrum disorder found significant improvements in social-emotional functioning outcomes [21].

Germane to schizophrenia, interest in employing physical exercise training to target clinical symptoms in this population has expanded substantially over the past two decades, as evident by the number of publications in PubMed (2000:12 → 2019:110). Individuals with schizophrenia, as well as those at clinical high risk of psychosis, tend to display highly sedentary lifestyles, resulting in poor aerobic fitness [22-24]. The bulk of the recent literature has centered on the impact of AE on neurocognition—findings from randomized clinical trials (RCT) by our group and others have demonstrated that AE leads to significant neurocognitive benefits [25-28], with improvements linked to exercise training fidelity [29].

Recent findings suggest AE may potentially benefit SF as well. Specifically, AE has been found to significantly improve a number of correlates of SF—a meta-analysis by Firth and colleagues [25] reported AE significantly improved social cognition, a predictor of real-world functioning [30]. Likewise, Dauwan et al. [31] found exercise training was superior to control conditions in improving negative symptoms, many of which index elements of social and affective functioning. Benefits were also noted for quality of life and global functioning. Consistent with these findings, Kern and colleagues [32] found improvements in social functioning were significantly related to gains in cardiorespiratory fitness (r = .42; p < .01) among 54 Veterans aged 40–65 years old with schizophrenia who were randomized to participate in a 12 week of AE or a non-aerobic stretching exercise intervention. Trend-level improvements in SF were seen in the AE group (p < .09), as well as trend level difference in the between-group comparison (p < .06; Cohen’s d = .35). However, at present, there are no studies directly examining the potential impact of AE on SF in schizophrenia. Furthermore, findings from previous reports are limited by reliance on clinician-administered measures of SF, which may potentially have poor ecological validity, with virtually no direct input from patients or informants/caregivers.

To address this gap in the literature, our aim was to examine the impact of AE on SF in individuals with schizophrenia, employing comprehensive, multi-method evaluations of SF indexed by self-, informant-, and clinician-reports. We hypothesized that AE-related increases in aerobic fitness would predict improvement in SF among individuals with schizophrenia.

Methods

Participants

Data were obtained from a pilot RCT conducted at a large hospital (ClinicalTrials.gov Identifier NCT01897064). The medical center’s institutional review board approved the study, and all participants provided written informed consent. Participants were recruited from outpatient mental health clinics in the greater New York City area. The inclusion criteria were a DSM-IV diagnosis of schizophrenia or related disorders; age 18–55 years; English-speaking; taking antipsychotic medication for at least 8 weeks and on current doses for 4 weeks and/or injectable depot antipsychotics with no change in the last 3 months; and medically cleared by a physician to take part in AE training. The exclusion criteria were a DSM-IV diagnosis of alcohol/substance abuse within the past month or alcohol/substance dependence within the past 6 months; recent use of street drugs (confirmed by a urine toxicology test); a history of seizures/head trauma with loss of consciousness resulting in cognitive sequelae/rehabilitation; significant clinical abnormalities in physical examination, electrocardiogram, or lab assessments; untreated hyper- or hypothyroidism; extreme obesity (BMI ≥ 40); being pregnant/nursing; having serious suicidal/homicidal risk; presence of moderate or more severe disorganization (SAPS global positive formal thought disorder ≥ 3); more than a mild level of depressive symptoms (BDI > 18); and participation in a study involving neurocognitive assessment in the previous 3 months. All data were collected between May 2012 and July 2014.

Sample Characteristics: Forty-one individuals consented to participate in the study. Eight participants discontinued their participation prior to randomization due to difficulties keeping research appointments (n = 3), psychotic exacerbation (n = 1), diagnosis of cancer (n = 1), discovery of a benign brain tumor (n = 1), BDI > 18 (n = 1), and conflict with changed school schedule (n = 1). The remaining 33 individuals were randomized (AE = 16, TAU = 17) of which 26 completed the study (79%). In the AE group, all three non-completers dropped-out during the first week of the AE training after 0, 1, and 3 sessions, respectively, due to loss of contact (n = 1), long commute-time to AE site (n = 1), and not liking the AE program (n = 1). In the TAU group, four participants dropped-out due to relocation (n = 1), hypomanic episode (n = 1), and protocol violations (n = 2). The status of 3 of the 33 randomized participants (9%) became un-blinded to raters - 1 in the TAU group (self-disclosure) and 2 in the AE group (1 self-disclosure, 1 accidental disclosure by clinical staff). Of note, we did not exclude participants who were prescribed beta-blockers or other medications known to influence heart rate out of concern that such exclusion would result in a non-representative sample as individuals with schizophrenia may be prescribed such medications for cardiac and/or other problems (e.g., akathisia). Only 2 out of the 33 randomized participants (6%) were prescribed beta-blockers.

Measures

Clinical assessments

Diagnoses were established using The Structured Clinical Interview for DSM-IV. Clinical symptoms were assessed using the Scales for Assessment of Positive and Negative Symptoms (SAPS/SANS) [33, 34] and the Beck depression and anxiety inventories (BDI; Beck Depression Inventory, BAI; Beck Anxiety Inventory) [35, 36].

Aerobic fitness

Aerobic fitness was determined by a cardiopulmonary exercise test to establish VO2 peak, an index of the maximum capacity of an individual’s body to transport and use oxygen during incremental AE activity. All tests were completed on weekdays at ~ 10 am and were performed on an electronically braked cycle ergometer [37] with a Viasys Encore metabolic cart [38]. The equipment was calibrated prior to every test. Continuous 12-lead telemetry was monitored via CardioSoft electrocardiogram software [39]. Participants completed a 5-min resting baseline, a 3 min of no-resistance warm-up, and a ramping exercise protocol of 10–15 watts to peak exercise with a target of exercise for 8–12 min. Exercise was terminated when the subject reached maximum capacity (VO2 plateau; 85% of maximal heart rate (HRmax; 220-age); respiratory quotient ≥ 1.1; or self-reported exhaustion indexed via Borg Scale). A 3-min active recovery period completed the test. We used VO2 peak scores (ml/kg/min) in all analyses.

Social functioning

We employed three complementary measures of SF including self-reports (Provision of Social Relations Scale, PSRS) [40], informant reports (Specific Levels of Functioning Scale, SLOF) [41], and clinician-administered interviews (Scale for the Assessment of Negative Symptoms, SANS) [33]. The PSRS is a 15-item self-report scale measuring social relationships with family and friends. Items are scored on a 5-point scale (from 1 = “Very much like me” to 5 = “Not at all like me”) with higher scores indicating lower support and relationship quality. The PSRS was found to have alpha coefficients of 0.85, 0.80, and 0.78 among individuals with schizophrenia, bipolar disorder, and healthy controls, respectively [42], as well as solid test–retest reliability of 0.75–0.87 [43]. The SLOF is a 43-item scale assessing multiple domains of daily functioning. Items are rated on a 5-point Likert scale with total scores ranging from 43 to 215 and higher scores indicating better overall functioning. The SLOF was found to have alpha reliability of 0.62 [41]. An informant version of the SLOF was administered to caregivers of all study participants, typically first-degree relatives who were in regular contact with study participants. For data analyses, we used the total score of the SLOF’s Interpersonal Relations subscale. The SANS is a 25-item clinician-administered scale developed to measure negative symptoms in schizophrenia, which have been linked to SF [44]. Items are rated on a 6-point scale (range 0–5), with higher scores reflecting increased severity. For the purposes of assessing SF, we used an Asociality subscale item from the SANS, which indexes the ability to feel intimacy and closeness with others (item #20). The interrater reliability for this individual item of the SANS was found to be 0.90 [33].

Demographic, clinical, and social network information

Demographic and clinical information was collected including age, sex, primary language, reading ability, and baseline prescription of antipsychotic medication (as indexed by chlorpromazine equivalence). Additionally, we characterized the participants’ social network, as indexed by item #5 of the Heinrichs-Carpenter Quality of Life Scale (QLS) [45], a semi-structured interview. The item indexes the scope and degree of the participant’s involvement in her/his social network—the extent to which other people concern themselves with the participant, care about her/his fortunes, or know about her/his activities.

Study design and blinding

We employed a proof-of-concept parallel assignment, single-blind RCT design with participants randomized to receive standard psychiatric treatment (“treatment as usual”; TAU) or attend a 12-week AE program in addition to TAU. Participants were randomized in the order they entered the study. After satisfying the inclusion/exclusion criteria, participants completed the diagnostic, clinical, aerobic fitness, and SF measures. Raters conducting clinical interviews and informant surveys, as well as the technicians conducting the aerobic fitness assessments, were blind to the participants’ treatment status. Following the 12-week period, participants completed a follow-up assessment of clinical, aerobic fitness, and SF measures. Participants received $270 for completing the research assessments. Additionally, those randomized to the AE arm received $5 reimbursement for each AE session they attended (paid weekly) to defray the costs of round-trip public transportation.

Interventions: description and fidelity assessments

All participants received standard psychiatric care over the course of the study, which included regular meetings with a psychiatrist, psychologists, social workers, and/or psychiatric nurses as determined by their pre-study individual treatment plan. Treatment schedules were determined for each participant by their clinical team and no attempts were made to inform or influence treatment.

Participants randomized to the AE intervention underwent a 12-week, 3 sessions/week, 1-hour AE training program informed by the American College of Sports Medicine and federal guidelines, which recommend 150 min of moderate-intensity AE per week. Moderate-intensity AE involves activities that expend 3.0–5.9 times the energy expended at rest and are broadly defined as activities in which the participant is able to talk while engaging in the activity. All AE sessions were held in a small gym located in the medical center. The AE equipment included two treadmill machines, a stationary bike, an elliptical machine, and two active-play video game systems (Xbox 360 Kinect, Microsoft) with whole-body exercise software [29, 46]. The AE sessions were led by a certified exercise trainer (B.S. degree in Therapeutic Recreation). The sessions opened with a 10-min trainer-led warm-up period, followed by 45-min AE using the equipment, and ended with a 5-min cool-down period. The trainer was present during all AE sessions for guidance and support, along with a research assistant who assisted with equipment set-up and collection of AE-related behavioral data.

Training fidelity was indexed by 1) the number of AE sessions attended over the 12-week program (maximum 36) and 2) in-session AE intensity. The latter was set for participants individually based on their maximal heart rate (HRmax), as determined during their baseline VO2 peak assessment. Target minimal AE intensity was set to 60% of HRmax in Week 1, 65% in Week 2, 70% in Week 3, and 75% in Weeks 4–12. In-session training intensity was monitored using Polar RS400 HR monitors (a wireless-enabled digital watch and chest strap) that participants wore during each session. The monitors were programmed to emit a soft beep when the participant’s HR was lower than the individually targeted AE intensity level, which cued the trainer to encourage the participant to achieve their individual target goal.

Data Analyses: Data analyses were conducted using IBM SPSS ver. 25. All tests were two-tailed and the significance level was α = .05. Determination of predictors of change in SF from baseline to 12-week follow-up was examined using three hierarchical step-wise regression analyses, using data from the PSRS, SLOF, and SANS as dependent variables. Change in aerobic fitness was entered in block 1 and demographic and clinical variables were entered in block 2. Clinical and demographic variables included age, sex, baseline antipsychotic medication use, baseline anxiety and depression scores, and baseline social network. Shapiro–Wilk tests indicated that the primary dependent variables were normally distributed. The AE and TAU intervention groups were compared using multivariate analyses of variance with a repeated-measures design, with time and group designated as within-subject and between-subject factors, respectively. We focused our analyses on study completers, but also present results using an intention-to-treat approach with baseline observations carried forward.

Results

The sample’s demographic and clinical characteristics are presented in Table 1. There were no significant group differences at baseline with regard to demographic, clinical, and physical health indices. There were also no significant group differences at baseline with regard to social functioning as indexed by self-, informant-, and clinician-indexed ratings, as well as social networks. Additionally, there were no significant differences between groups in the number of clinical contacts with mental-health professionals (psychiatrists, psychologists, social workers, and/or psychiatric nurses) during the month prior to the 12-week follow-up assessments (AE: mean 5.00 meetings, SD 4.91 vs. TAU: mean 4.73, SD 6.09; t = 0.12, p = .91). Changes in SF over the course of 12 weeks were not associated with changes in prescription of antipsychotic, antidepressant, or SSRI medications. Likewise, no changes were reported in smoking status.

Table 1

Baseline demographic and clinical characteristics

	Aerobic exercise (n = 16)	Treatment as usual (n = 17)	t/X2	p
Age	36.56 (10.37)	37.24 (9.85)	.19	.85
Sex (% female)	37%	35%	.02	.89
Ethnicity (% Hispanic)	43%	29%	.69	.39
Race
Caucasian	2 (13%)	6 (35%)	2.97	.40
Black/African–American	6 (37%)	6 (35%)
Asian	2 (13%)	2 (12%)
More than one race	6 (37%)	3 (18%)
Symptoms
Positive (SAPS global total)	3.77 (3.37)	3.46 (2.93)	.25	.81
Negative (SANS global total)	9.73 (4.24)	8.54 (4.41)	.67	.51
Depression (BDI total)	7.81 (7.69)	7.23 (8.57)	.20	.84
Anxiety (BAI total)	4.56 (4.40)	5.82 (6.83)	.63	.54
Medications
Antipsychotics (Chlorpromazine Equival.)	258.85 (232.51)	439.73 (362.78)	1.69	.10
Antidepressants (% yes)	44%	35%	.25	.62
SSRIs (% yes)	31%	23%	.25	.62
Social functioning
Self-report (PSRS)	34.00 (15.13)	29.76 (9.67)	.96	.34
Informant (SLOF Interpersonal Total)	4.75 (2.52)	3.65 (2.76)	1.20	.24
Clinician (SANS Item #20)	2.06 (1.39)	1.76 (1.44)	.61	.55
Social Network (QLS Item #5)	3.56 (1.46)	4.00 (1.94)	.73	.47
Aerobic Fitness (VO2 peak ml/kg/min)	21.21 (7.69)	22.88 (4.41)	.77	.45
Body Mass Index	31.60 (6.57)	30.75 (5.51)	.40	.69

n = 33 (schizophrenia = 26; schizoaffective disorder = 7); SAPS, Scale for Assessment of Positive Symptoms; SANS, Scale for Assessment of Negative Symptoms; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; SSRI, Serotonin-Specific Reuptake Inhibitor; PSRS, Provision of Social Relations Scale; SLOF, Specific Level of Functioning—Informant version; SANS, Scale for the Assessment of Negative Symptoms; QLS, Quality of Life Scale; VO2peak – maximum oxygen consumption

AE training: safety, attendance, and in-session engagement

Of the 16 participants assigned to the AE track, 13 successfully completed the training program (81%). No serious adverse events were associated with the AE training. Participants attended 28.5 of the 36 scheduled AE sessions on average (79%; range 44%–97%; 2.4 sessions per week on average). Two to three participants typically attended each AE session. They exercised individually and were free to choose which AE equipment they wanted to use, as well as free to take breaks and hydrate as needed (breaks typically lasted 1–2 min).

During each AE session, participants engaged in active AE training on average for 42.7 min/session (SD 3.51). Thirty-nine percent of this time was spent using the Xbox 360 Kinect, followed by the treadmill (32%), stationary bike (13%), elliptical machine (13%), and trainer-led AE activities (3%). On average, during 25% of the time during AE sessions, the participants’ HR was between 60% and 69% of their HRmax, 27% between 70% and 79%, 21% between 80% and 89%, and 16% of the sessions at ≥ 90% of HRmax. During only 11% of the sessions was the participants’ HR below the initial designated training goal of 60% of HRmax.

Efficacy of aerobic exercise training to improve aerobic fitness

Results on the impact of AE on aerobic fitness have been published previously [26]. Briefly, at follow-up, the AE participants improved their VO2max by 18.0% versus − 0.5% in the controls (group x time interaction, F1,24 = 12.88; p = .002).

Predictors of improvement in social functioning

Using a hierarchical step-wise regression analysis, we evaluated the impact of changes in AF and other predictor variables on SF. As shown in Table 2, the regression analysis indicated that for change in PSRS (i.e., self-reported SF), a model incorporating change in aerobic fitness, age, and baseline social network, significantly accounted for 47% of the explained variance in SF improvement (F1,25 = 6.395, p = .003), with change in aerobic fitness accounting for 22% of the explained variance (F1,25 = 6.619, p = .017; See Fig. 1). For change in SLOF (i.e., informant-reported SF), a model incorporating change in aerobic fitness and baseline anxiety significantly accounted for 33% of the explained variance in SF improvement (F1,25 = 5.617, p = .01). For change in SANS item 20 (i.e., clinician-rated SF), a model incorporating change in aerobic fitness and baseline anxiety significantly accounted for 25% of the explained variance in SF improvement (F1,25 = 3.824, p = .037).

Table 2

Predictors of change in self-, informant-, and clinician-reported social functioning in individuals with schizophrenia

Dependent predictor variable	B	SE	Beta (β)	p	R2	Adj. R2	∆R2	∆Sig. F
Dependent variable: Change in self-reported social functioning (PSRS)
Step 1					0.22	0.18	0.22	0.02
Change in aerobic fitness	− 1.18	0.46	− 0.46	0.017
Step 2					0.36	0.31	0.15	0.03
Change in aerobic fitness	− 1.36	0.43	− 0.53	0.004
Age	− 0.39	0.17	− 0.39	0.032
Step 3					0.47	0.39	0.10	0.05
Change in aerobic fitness	− 1.84	0.46	− 0.72	0.001
Age	− 0.41	0.16	− 0.40	0.018
Baseline social network (QLS)	− 2.31	1.11	− 0.37	0.050
Dependent variable: Change in informant-reported social functioning (SLOF)
Step 1					0.07	0.03	0.07	0.19
Change in aerobic fitness	0.27	0.20	0.26	0.194
Step 2					0.33	0.27	0.26	0.01
Change in aerobic fitness	0.26	0.17	0.26	0.147
Baseline BAI	− 0.36	0.12	− 0.51	0.007
Dependent variable: Change in clinician-rated social functioning (SANS item 20)
Step 1					0.07	0.03	0.07	0.19
Change in aerobic fitness	− 0.08	0.06	− 0.27	0.186
Step 2					0.25	0.18	0.18	0.03
Change in aerobic fitness	− 0.04	0.06	− 0.15	0.434
Baseline BAI	1.03	0.44	0.44	0.029

n = 33; Aerobic fitness, VO2peak (ml/kg/min); PSRS Provision of Social Relations Scale, QLS Quality of Life Scale, SLOF Specific Level of Functioning, SANS Scale for the Assessment of Negative Symptoms; BAI Beck Anxiety Invent

Fig. 1

Association of Changes in Aerobic Fitness and Changes in Social Functioning in Individuals with Schizophrenia. Note: n = 33; PSRS—provision of Social Relations Scale; VO2 peak—maximum oxygen consumption

Efficacy of AE training to improve social functioning

Participants in the AE group who completed the study reported significant improvement in SF compared to the TAU group, as indexed by the PSRS (23.0% vs. − 4.2%; group × time interaction, F1,24 = 7.48, p = .012; see Table 3). Results for the SANS and SLOF did not reach significance. Cohen’s d calculation indicated a large effect size for the AE intervention on the PSRS (d = 0.89), a small effect size for the SANS asociality items (d = 0.19), and a medium effect size for the SLOF interpersonal subscale administered to caregivers (d = 0.69).

Table 3

Comparison of changes in self-, informant-, and clinician-reported social functioning following aerobic exercise or treatment-as-usual

Treatment	Intention to Treat (n = 33)				Study Completers (n = 26)
	Mean Δ	SD	Fa	p	Mean Δ	SD	Fa	p	Cohen’s db
PSRS
TAU	2.94	12.28	1.80	0.19	6.54	10.43	6.19	*0.02	0.89
AE	− 1.31	6.83			− 1.62	7.60
SANS
TAU	− 0.76	5.33	0.54	0.47	− 0.46	2.07	0.32	0.58	0.19
AE	− 1.00	5.74			− 0.85	1.99
SLOF
TAU	− 1.18	3.61	2.65	0.11	− 1.38	4.11	1.57	0.22	0.69
AE	1.00	3.16			1.23	3.49

*p < .05; TAU treat-as-usual, AE aerobic exercise, PSRS Provision of Social Relations Scale, SANS Scale for the Assessment of Negative Symptoms (Item 20); SLOF Specific Level of Functioning (informant version) – Interpersonal domain; Lower scores on the PSRS & SANS and higher scores on the SLOF indicate better social functioning; aControlling for the impact of sex, age, and changes in antipsychotic medication; bFor study completers

Discussion

To the best of our knowledge, the present report is the first comprehensive examination of the impact of AE on SF in individuals with schizophrenia. Our group had previously documented significant benefits of AE-related enhancement in aerobic fitness on neurocognition in this population [26]. Our results indicate that the benefits of enhancing aerobic fitness extend to SF, particularly as indexed by participants’ self-reported experiences of social interactions. Notably, the models for informant- and clinician-rated SF provide additional support for the validity of our findings, though they were significant only after baseline level of anxiety was entered into the models.

As there are currently few effective treatments for social dysfunction in schizophrenia, our results, as well as the recent findings by Kern et al. [32], provide preliminary support for a novel intervention approach that target enhancement of aerobic fitness to improve poor SF in this population. This modality has advantages over available interventions in that it not only improves SF, but also enhances neurocognition [25, 26], cardiovascular functioning [29], as well as overall physical health. Additionally, our results suggest AE is a non-stigmatizing, safe, and nearly side-effect-free intervention, suggesting an intervention profile with a promise for broad dissemination. This view is consistent with the European Psychiatric Association’s position paper and treatment guidelines advocating dissemination of physical activity as part of treatment for individuals with severe mental illness, [47] as well as previous reports for dissemination among fist-episode patients [48]. Additionally, within the context of the current COVID-19 pandemic, recent reports suggest AE may help protect against development of severe psychopathology [49].

Our results raise an important question about the mechanism underlying SF benefits. Specifically, whether, and to what extent, the SF benefits associated with AE were due to the increased availability of opportunities to engage in social interaction during AE sessions. While we cannot completely discount this explanation, it is unlikely given that typically the AE sessions involved only 2–3 attendees per session; all participants exercised individually at different locations within the gym; and there were no attempts by staff to encourage social interactions between participants. Thus, participants typically had minimal interpersonal interactions during sessions. However, future studies should aim to formally assess this potential influence via use of an active control intervention. Our group [48] is currently examining this issue as part of a larger RCT employing AE and a stretching-and-toning, non-aerobic control intervention that offers identical opportunities for social interactions, as well as similar intervention duration, frequency, facilities, format (e.g., indoor space; small group), trainer contact, and financial compensation (i.e., reimbursement of exercise travel expenses), while not influencing aerobic fitness.

Similarly, as the inclusion/exclusion criteria for the study excluded individuals with moderate or more severe symptoms of depression, it is unlikely that the results were driven by reduction in depressed mood. However, to control for this potential effect of baseline mood symptoms, we included both baseline anxiety and depression as covariates in our analysis. Conversely, previous reports indicate that emotional processing difficulties, particularly difficulties in emotion awareness and regulation, have been shown to be significant predictors of SF among individuals with schizophrenia and at clinical high risk for psychosis [22, 29, 50]. Thus, future studies should aim to examine whether the SF benefits of AE among individuals with schizophrenia-spectrum disorders are mediated by changes in emotion awareness and regulation.

Our results invite speculation about the putative neural circuitry that links AE-related changes in aerobic fitness and enhanced SF. Impairments in SF in schizophrenia have been attributed, in large part, to deficits in social cognition [12, 51]. Specifically, deficits in the domains of emotion awareness and regulation, cognitive control, attribution, and theory of mind have been proposed to play a central role in determining SF in schizophrenia [50, 52, 53]. These domains have been linked to structural and functional abnormalities in the hippocampus, amygdala, ventral striatum, temporoparietal junction (TPJ), and posterior cingulate [54]. While data from imaging studies directly examining the link between AE and SF in schizophrenia are scarce, a number of recent reviews of studies employing structural MRIs have indicated volume increases in the hippocampus and cortical regions following exercise training [27, 55, 56], although these findings are not universal. In particular, the hippocampus has been identified as a potential locus for illness severity and poor social functioning in schizophrenia [57], and research suggests that smaller hippocampal volume may result in increased stress sensitivity in first-episode schizophrenia [58]. Furthermore, pre-clinical and clinical studies have also indicated effects of AE on the hypothalamus–pituitary–adrenal axis, growth factors (e.g., Brain-Derived Neurotrophic Factor), immune-related mechanisms, as well as some effects on neurotransmitters and the endocannabinoid system [55].

Likewise, recent reports have linked a number of indices of cardiac autonomic regulation, which are positively responsive to AE, to correlates of SF in individuals with schizophrenia. In particular, Hamilton and colleagues [59] demonstrated that respiratory sinus arrhythmia (RSA) and social cognition interact to predict functioning in this population. Specifically, RSA did not enhance functional outcomes when social cognition was already strong, but higher levels of RSA enabled effective role functioning when social-cognitive performance was impaired. Jointly, RSA and social cognition accounted for 40% of the variance in outcome success, compared with 21% when evaluating social cognition alone. More recently, our group [60] has documented links between lower autonomic arousal characterized by higher vagal input and metacognitive difficulties, which have been hypothesized to impact affective responses to social interactions [61]. These reports are consistent with reviews linking insular cortex functioning, which is heavily involved in autonomic arousal, and processing of social emotions and functioning [62]. Altogether, these findings are suggestive of a link between AE and enhanced neuroplasticity supporting improvement in SF. Future studies should confirm whether changes in these specific brain regions mediate the link between AE-related improvements in aerobic fitness and enhanced SF.

Our study has a number of strengths including a comprehensive, multi-method assessment of SF; state-of-the-art characterization of aerobic fitness; as well as granular, high temporal-resolution monitoring of in-session AE intervention fidelity. The latter is particularly important given that AE training characteristics (e.g., frequency, duration, and in-session intensity) may have significant impact on outcomes and thus are critical for design and dissemination of future intervention studies. AE training characteristics may also allow enhance replicability as well as allow comparison between studies with divergent findings. Our study has a number of limitations bear mentioning. First, the modest sample size suggests our results and conclusions should be viewed as preliminary. Future studies should aim to replicate our findings with larger samples. Second, the exclusion of individuals with schizophrenia with more than moderate symptoms of depression, as well as those regularly using substances, may potentially limit the generalizability of our findings. Third, our evaluations of SF all involved retrospective recollection of the participants’ social activities by themselves (via self-reports and clinical interviews) and informants. Such evaluations are vulnerable to the influence of poor episodic memory, emotional states at the time of the evaluation, as well as cognitive biases and reframing [63]. This issue is particularly critical in studies of individuals with schizophrenia given the substantial episodic memory deficits documented in this population [64]. Consistent with these findings, our group has documented memory difficulties have a detrimental impact on accuracy of recollected experiences among individuals with schizophrenia [65]. To address this issue, future studies should aim to complement traditional retrospective assessments with ambulatory “in vivo, in situ” real-world evaluations of social interactions that would minimize the impact of reporting biases and offer higher ecological validity [66]. Finally, the lack of an active control group diminished our ability to examine the potential influence of opportunities for social contact on SF outcomes. Future studies should aim to examine the impact of AE on SF among such individuals. Our group recently started a large project that would be able to address some of these limitations [48].

In summary, our results indicate that AE is effective in improving SF in people with schizophrenia, particularly as indexed by study participants and their caregivers. Poor aerobic fitness represents a modifiable risk factor for social dysfunction in schizophrenia for which AE training offers a non-stigmatizing, safe, and nearly side-effect-free intervention.